Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1341332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Qi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Shihezi University, Shihezi, China. Hauptthemen laut MEDLINE: Hemorrhagic Fever Virus, Crimean-Congo, Antibodies, Neutralizing, Antibodies, Viral, Neutralization Tests. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The Crimean-Congo hemorrhagic fever virus (CCHFV), the most geographically widespread tick-borne virus, is endemic in Africa, Eastern Europe and Asia, with infection resulting in mortality in up to 30% of cases. Currently, there are no approved vaccines or effective therapies available for CCHF. The CCHFV should only be manipulated in the BSL-4 laboratory, which has severely hampered basic seroprevalence studies.
Methods
In the present study, two antibody detection methods in the forms of an enzyme-linked immunosorbent assay (ELISA) and a surrogate virus neutralization test (sPVNT) were developed using a recombinant glycoprotein (rGP) and a vesicular stomatitis virus (VSV)-based virus bearing the CCHFV recombinant glycoprotein (rVSV/CCHFV) in a biosafety level 2 (BSL-2) laboratory, respectively.
Results
The rGP-based ELISA and rVSV/CCHFV-based sVNT were established by using the anti-CCHFV pre-G C mAb 11E7, known as a broadly cross-reactive, potently neutralizing antibody, and their applications as diagnostic antigens were validated for the specific detection of CCHFV IgG and neutralizing antibodies in experimental animals. In two tests, mAb clone 11E7 (diluted at 1:163840 or 512) still displayed positive binding and neutralization, and the presence of antibodies (IgG and neutralizing) against the rGP and rVSV/CCHFV was also determined in the sera from the experimental animals. Both mAb 11E7 and animal sera showed a high reactivity to both antigens, indicating that bacterially expressed rGP and rVSV/CCHFV have good immunoreactivity. Apart from establishing two serological testing methods, their results also demonstrated an imperfect correlation between IgG and neutralizing antibodies.
Discussion
Within this limited number of samples, the rGP and rVSV/CCHFV could be safe and convenient tools with significant potential for research on specific antibodies and serological samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Shihezi University, Shihezi, China.
- Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
- College of Veterinary Medicine, Jilin University, Changchun, China.
Zitieren
APA
Wang, Q., Wang, S., Shi, Z., Li, Z., Zhao, Y., Feng, N., Wang, T., Yan, F., & Xia, X. (2024). Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1341332
Vancouver
Wang Q, Wang S, Shi Z, Li Z, Zhao Y, Feng N, et al. Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1341332
BibTeX
@article{Wang2024,
author = {Wang, Qi and Wang, Shen and Shi, Zhikang and Li, Zhengrong and Zhao, Yongkun and Feng, Na and Wang, Tiecheng and Yan, Feihu and Xia, Xianzhu},
title = {Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1341332}
}
EUVIMED